ArticleFrontiers in immunology2026
Unveiling the clinical and proteomic spectrum of relapsing polychondritis with respiratory involvement.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Relapsing polychondritis (RP) is a rare autoimmune disease characterized by recurrent inflammation and progressive damage to cartilage. Respiratory involvement, which has a relatively high misdiagnosis rate, is the leading cause of death in RP patients, and its underlying pathogenesis remains largely unknown. Methods: Seventy-seven RP patients with respiratory involvement were enrolled in this study. The clinical characteristics, including imaging features, bronchoscopic findings, and treatment, were systematically analyzed. Latent class analysis (LCA) was used to classify patients at first hospitalization according to their bronchoscopic findings, and the relevant clinical parameters were evaluated. A proteomic technique was applied to detect proteins in the peripheral serum of healthy controls (HCs) and 35 patients. The differentially expressed proteins between these two groups were analyzed and verified by Western blot. Results: Patients with initial respiratory involvement were less likely to have ear chondritis (14.29% vs 42.86%, Conclusions: Clinical manifestations of respiratory-involved RP are nonspecific, and recognition of imaging and bronchoscopic features can facilitate the diagnosis. Patient stratification based on the patterns of airway involvement can help guide airway management strategies. Additionally, abnormalities of the complement system and NETs may play a role in its pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.